Monte Rosa Therapeutics Inc (GLUE)
$10.76 -1.01% Close Oct 30, 2026 Live
Monte Rosa Therapeutics stock today
Monte Rosa Therapeutics closed at $10.76 on October 30, 2026, down 1.01% on the day. Over the past year it returned -17.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $909 million.
$10.00$15.00$20.00$25.00
NovJan 2026MarMayJulSep
| Period | GLUE | S&P 500 (SPY) |
|---|---|---|
| 1 month | -9.8% | -0.9% |
| 3 months | -52.6% | +2.1% |
| Year to date | -31.4% | +11.7% |
| 1 year | -17.3% | +12.4% |
| 3 years | +247.1% | +88.5% |
| 5 years | -54.1% | +76.0% |
Key statistics
- Market value
- $909M
- Price / sales
- 31.6
- 52-week range
- $9.74 to $25.31
- Next report
- Nov 5, 2026 (estimated)
About Monte Rosa Therapeutics
Monte Rosa Therapeutics develops small-molecule drugs targeting protein degradation for oncology and other diseases.
Sector: Health Care
More on Monte Rosa Therapeutics
- Returns: what $1,000 became$1,000 five years ago is $458.85 today
No forecast, no recommendation. This page describes Monte Rosa Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.